India, March 17 -- Early stage investment firm Venture Catalysts took a full exit from hygiene and wellness startup Pee Safe during its $32 Mn Series C raise from OrbiMed in January this year.

The firm exited Pee Safe with a 9.6X return on its initial investment at a 30.53% extended internal rate of return (XIRR). Venture Catalysts was one of Pee Safe's earliest backers, having first invested in the femtech startup in 2017 during its pre-Series round worth $1 Mn.

"This exit is a validation of patient early stage investing where we back founders before the market agrees. Pee Safe built category depth, distribution muscle, and brand trust. Delivering cash returns, not just markups, strengthens our promise to LPs and energises our next cyc...